WO2003011299A3 - Procede et composition pour le traitement de l'hypertension oculaire et des glaucomes - Google Patents

Procede et composition pour le traitement de l'hypertension oculaire et des glaucomes Download PDF

Info

Publication number
WO2003011299A3
WO2003011299A3 PCT/JP2002/007699 JP0207699W WO03011299A3 WO 2003011299 A3 WO2003011299 A3 WO 2003011299A3 JP 0207699 W JP0207699 W JP 0207699W WO 03011299 A3 WO03011299 A3 WO 03011299A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
glaucoma
ocular hypertension
micrograms
keto
Prior art date
Application number
PCT/JP2002/007699
Other languages
English (en)
Other versions
WO2003011299A2 (fr
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Ryuji Ueno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag, Ryuji Ueno filed Critical Sucampo Ag
Priority to CA002454422A priority Critical patent/CA2454422A1/fr
Priority to JP2003516529A priority patent/JP2004538306A/ja
Priority to EP02751774A priority patent/EP1411950A2/fr
Priority to MXPA04000980A priority patent/MXPA04000980A/es
Priority to KR10-2004-7001587A priority patent/KR20040023707A/ko
Priority to BR0211545-0A priority patent/BR0211545A/pt
Priority to US10/485,370 priority patent/US20040254247A1/en
Publication of WO2003011299A2 publication Critical patent/WO2003011299A2/fr
Publication of WO2003011299A3 publication Critical patent/WO2003011299A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention se rapporte à un procédé servant à traiter l'hypertension oculaire et les glaucomes et qui consiste à administrer en mode topique dans les yeux d'un sujet mammifère nécessitant un tel traitement plus de 5 νg et moins de 50 νg par oeil par administration d'un composé de 15-céto-prostaglandine comportant une structure cyclique à l'extrémité de la chaîne φ. Le traitement faisant l'objet de cette invention ne produit pour ainsi dire pas d'effets secondaires irritants l'oeil ou en produit à un niveau réduit, même à une telle dose élevée.
PCT/JP2002/007699 2001-07-31 2002-07-30 Procede et composition pour le traitement de l'hypertension oculaire et des glaucomes WO2003011299A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA002454422A CA2454422A1 (fr) 2001-07-31 2002-07-30 Procede et composition pour le traitement de l'hypertension oculaire et des glaucomes
JP2003516529A JP2004538306A (ja) 2001-07-31 2002-07-30 高眼圧症および緑内障の処置
EP02751774A EP1411950A2 (fr) 2001-07-31 2002-07-30 Procede et composition pour le traitement de l'hypertension oculaire et des glaucomes
MXPA04000980A MXPA04000980A (es) 2001-07-31 2002-07-30 Tratamiento de hipertension ocular y glaucoma.
KR10-2004-7001587A KR20040023707A (ko) 2001-07-31 2002-07-30 안내압항진 및 녹내장의 치료
BR0211545-0A BR0211545A (pt) 2001-07-31 2002-07-30 Método e composição para tratamento de hipertensão ocular e glaucoma
US10/485,370 US20040254247A1 (en) 2001-07-31 2002-07-30 Method and composition for treatnment of ocular hypertension and glaucoma

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30858901P 2001-07-31 2001-07-31
US60/308,589 2001-07-31

Publications (2)

Publication Number Publication Date
WO2003011299A2 WO2003011299A2 (fr) 2003-02-13
WO2003011299A3 true WO2003011299A3 (fr) 2003-10-30

Family

ID=23194562

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/JP2002/007699 WO2003011299A2 (fr) 2001-07-31 2002-07-30 Procede et composition pour le traitement de l'hypertension oculaire et des glaucomes
PCT/US2002/024072 WO2003011178A2 (fr) 2001-07-31 2002-07-31 Procede de traitement pour l'hypertension oculaire et le glaucome

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2002/024072 WO2003011178A2 (fr) 2001-07-31 2002-07-31 Procede de traitement pour l'hypertension oculaire et le glaucome

Country Status (8)

Country Link
EP (1) EP1411950A2 (fr)
JP (1) JP2004538306A (fr)
KR (1) KR20040023707A (fr)
CN (1) CN1646134A (fr)
BR (1) BR0211545A (fr)
CA (1) CA2454422A1 (fr)
MX (1) MXPA04000980A (fr)
WO (2) WO2003011299A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005519978A (ja) * 2002-03-28 2005-07-07 スキャンポ・アーゲー 高眼圧症および緑内障の処置方法
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
US7605178B2 (en) * 2006-07-10 2009-10-20 Allergan, Inc. Therapeutic compounds
US20080015219A1 (en) * 2006-07-11 2008-01-17 Allergan, Inc. Therapeutic compounds
WO2008008718A2 (fr) * 2006-07-11 2008-01-17 Allergan, Inc. Composés thérapeutiques
NZ582705A (en) * 2007-07-03 2012-06-29 Allergan Inc Therapeutic substituted cyclopentanes for reducing intraocular pressure

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366279A2 (fr) * 1988-10-01 1990-05-02 R-Tech Ueno Ltd. Agents oculaires hypotenseurs
WO2001068072A2 (fr) * 2000-03-16 2001-09-20 Sucampo Ag Traitement de l'hypertension oculaire et du glaucome
WO2002007731A2 (fr) * 2000-07-20 2002-01-31 Sucampo Ag Composition destinee au traitement de l'hypertension oculaire et du glaucome

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366279A2 (fr) * 1988-10-01 1990-05-02 R-Tech Ueno Ltd. Agents oculaires hypotenseurs
WO2001068072A2 (fr) * 2000-03-16 2001-09-20 Sucampo Ag Traitement de l'hypertension oculaire et du glaucome
WO2002007731A2 (fr) * 2000-07-20 2002-01-31 Sucampo Ag Composition destinee au traitement de l'hypertension oculaire et du glaucome
US20020035149A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension and glaucoma

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STJERNSCHANTZ J ET AL: "MICROVASCULAR EFFECTS OF SELECTIVE PROSTAGLANDIN ANALOGUES IN THE EYE WITH SPECIAL REFERENCE TO LATANOPROST AND GLAUCOMA TREATMENT", PROGRESS IN RETINAL AND EYE RESEARCH, OXFORD, GB, vol. 19, no. 4, July 2000 (2000-07-01), pages 459 - 496, XP001126960, ISSN: 1350-9462 *

Also Published As

Publication number Publication date
EP1411950A2 (fr) 2004-04-28
WO2003011299A2 (fr) 2003-02-13
CA2454422A1 (fr) 2003-02-13
JP2004538306A (ja) 2004-12-24
BR0211545A (pt) 2004-07-13
MXPA04000980A (es) 2004-04-20
WO2003011178A2 (fr) 2003-02-13
KR20040023707A (ko) 2004-03-18
CN1646134A (zh) 2005-07-27

Similar Documents

Publication Publication Date Title
CA2502437A1 (fr) Procede et composition contenant du latanoprost destines au traitement de l'hypertension oculaire et d'un glaucome
TWI255714B (en) Method for treating meibomian gland disease
WO2002096432A3 (fr) Compositions a base de timolol et de lipide hypotenseur et methodes d'utilisation associees
WO2002036162A3 (fr) Compositions et methodes de traitement de la neovascularisation oculaire et des lesions nerveuses
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
CA2440764A1 (fr) Combinaison de brimonidine et de timolol pour utilisation topique ophtalmique
BR9808016A (pt) Composições e métodos para redução da hipertensão ocular
WO2004008990A3 (fr) Correction progressive d'une erreur de refraction de la cornee au moyen d'elements rapportes multiples
CA2198245A1 (fr) Methodes et moyens pour l'administration de medicaments
HK1015691A1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia.
WO2003053336A3 (fr) Procedes de traitement de malaises neurovasculaires peripheriques
WO2000018316A3 (fr) Composition ophtalmique agreable, a liberation prolongee, et procede de therapie oculaire
WO2002009702A3 (fr) Methode de reduction de la pression intraoculaire avec des derives d'indole
AU5446299A (en) Medicinal compositions for treating eye diseases
WO2001030380A3 (fr) Techniques et compositions destinees au traitement du keratocone au moyen d'inhibiteurs de protease
KR20130052619A (ko) 방부제가 없는 비마토프로스트 및 티몰롤 용액
EP1050308A4 (fr) Mesures prophylactiques ou remedes contre les troubles de la vision
WO1998039293A3 (fr) 13-thia prostaglandines destinees a etre utilisees dans la therapie du glaucome
CA2171226A1 (fr) Traitement de troubles au niveau du nerf optique a l'aide de composes de l'acide prostanoique
WO1999043309A3 (fr) Medicaments anticonvulsants et compositions pharmaceutiques de ceux-ci
WO2003011299A3 (fr) Procede et composition pour le traitement de l'hypertension oculaire et des glaucomes
WO2000074649A3 (fr) Compositions ophtalmiques a base d'histamine et leurs utilisations
AU609807B2 (en) A composition for the topical treatment of glaucoma or ocular hypertension
WO2002072105A3 (fr) Therapies a prostanoide ameliorees destinees au traitement du glaucome
JP5041761B2 (ja) 眼粘膜適用製剤

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2454422

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002751774

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003516529

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/000980

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1020047001587

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2002355693

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 20028190947

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2002751774

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10485370

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2002751774

Country of ref document: EP